secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardio Diagnostics Holdings, Inc. (CDIO)
CIK:        0001870144
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001079973-24-001660
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardio Diagnostics gets second Nasdaq extension to June 2, 2025 for bid price rule; may reverse split
--------------------------------------------------------------------------------

- Second Nasdaq letter grants 180-day extension until June 2, 2025, to meet $1.00 minimum bid price.
- Common stock (CDIO) and warrants (CDIOW) continue trading; no immediate delisting effect.
- Company will consider a reverse stock split, must complete it 10 business days before deadline.
- If not compliant by end of extension, Nasdaq will issue delisting notice; company may appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870144/000107997324001660/0001079973-24-001660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870144/000107997324001660/cdio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-001660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer